What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

RPA DNA Amplification: Principles and Applications

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to RPA DNA Amplification

What is RPA?

Recombinase Polymerase Amplification (RPA) is an isothermal nucleic acid amplification technology that enables the exponential amplification of specific DNA sequences at a constant, low temperature—typically between 37°C and 42°C. Developed in the early 2000s by Olaf Piepenburg and colleagues, RPA has emerged as a powerful alternative to the Polymerase Chain Reaction (PCR Explained) for applications requiring rapid, portable, and minimally instrumented DNA detection.

The fundamental innovation of RPA lies in its use of a recombinase enzyme to facilitate primer-target hybridization without the need for thermal denaturation of double-stranded DNA (dsDNA). In PCR, high temperatures (94–98°C) are required to separate the two strands of the DNA duplex so that primers can anneal. RPA instead employs a protein-driven strand exchange mechanism that operates at near-physiological temperatures, eliminating the need for a thermocycler and dramatically reducing the energy and equipment requirements for amplification.

RPA belongs to a broader family of isothermal amplification methods that includes Loop-Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence-Based Amplification (NASBA), and Strand Displacement Amplification (SDA). Among these, RPA is distinguished by its low operating temperature, rapid reaction kinetics (often reaching detectable levels within 5–20 minutes), and compatibility with a wide range of sample matrices, including crude lysates and whole blood.

RPA vs PCR: Key Differences

The differences between RPA and PCR are fundamental and extend beyond the obvious distinction of temperature cycling. The table below summarizes the key contrasts:

Feature	RPA	PCR
Temperature requirement	Constant 37–42°C	Cycling (94°C denaturation, 50–65°C annealing, 72°C extension)
Strand separation mechanism	Recombinase-mediated strand invasion	Thermal denaturation
Time to detectable product	5–20 minutes	1–3 hours (typically 30–40 cycles)
Instrumentation	Simple heat block or body heat	Thermocycler
Primer length	30–35 nucleotides	18–25 nucleotides
Primer design complexity	High; requires specialized software	Moderate; well-established rules
Tolerance to inhibitors	High; works in crude samples	Variable; often requires purified DNA
Multiplexing capability	Limited	Well-established

While PCR remains the gold standard for laboratory-based nucleic acid detection due to its robustness, quantitative accuracy, and vast ecosystem of validated assays, RPA offers distinct advantages for point-of-care diagnostics, field testing, and resource-limited settings. Understanding the mechanistic basis of RPA is essential for appreciating both its strengths and its limitations.

Core Components and Mechanism of RPA

Recombinase and Strand Invasion

The central protein component of RPA is a recombinase, typically the UvsX protein from bacteriophage T4. UvsX is a member of the RecA/Rad51 family of recombinases, which catalyze homologous recombination—the exchange of genetic information between two DNA molecules with complementary sequences.

In the RPA reaction, UvsX forms a nucleoprotein filament with single-stranded DNA (ssDNA) primers. This process requires ATP, which is hydrolyzed to ADP and inorganic phosphate to drive the conformational changes necessary for filament assembly and disassembly. The UvsX-primer filament then scans the double-stranded target DNA for a homologous sequence. Upon finding a match, the filament invades the duplex, displacing the complementary strand and forming a D-loop structure—a displacement loop where the invading primer base-pairs with its complementary target strand.

The displaced strand is immediately bound by single-stranded DNA binding proteins (SSBs), specifically the gp32 protein from bacteriophage T4. SSBs stabilize the displaced strand and prevent it from re-annealing to its complement, maintaining the open complex required for polymerase access.

The polymerase used in RPA is a large fragment of the Bacillus subtilis Pol I homolog, known as Bsu DNA polymerase. This enzyme possesses strand displacement activity, meaning it can synthesize DNA while displacing the downstream strand ahead of it. Bsu polymerase lacks 5'→3' exonuclease activity, which is critical for preventing primer degradation during the reaction. The polymerase extends the invading primer, synthesizing a new complementary strand and displacing the original strand, which is coated by SSBs.

The reaction proceeds through repeated cycles of filament formation, strand invasion, and extension. Each newly synthesized strand can serve as a template for subsequent rounds of invasion by new primer-filament complexes, leading to exponential amplification. The entire process occurs at a constant temperature because all enzymatic steps are optimized for 37–42°C.

Primer Design and Requirements

Primer design for RPA differs substantially from PCR primer design. The most striking difference is primer length: RPA primers are typically 30–35 nucleotides long, compared to 18–25 nucleotides for PCR primers. This length requirement stems from the mechanism of recombinase loading. UvsX binds to ssDNA in a cooperative manner, requiring a minimum length of approximately 20–30 nucleotides to form a stable nucleoprotein filament. Shorter primers fail to load sufficient recombinase molecules and exhibit poor strand invasion efficiency.

Additional primer design considerations include:

GC content: Aim for 40–60% GC content, similar to PCR primers, but avoid long homopolymer runs and repetitive sequences that could promote secondary structure formation.
Melting temperature: While PCR primers are designed with specific melting temperatures (Tm) for annealing, RPA primers do not require a precise Tm because hybridization occurs via recombinase-mediated strand invasion rather than thermal annealing. However, primers with very high or very low GC content may still perform poorly.
Avoiding secondary structure: Primers must not form stable hairpins or self-dimers, as these structures can sequester the primer and prevent recombinase loading.
Target region: The amplicon size for RPA is typically 100–200 base pairs, though products up to 500 base pairs can be amplified with reduced efficiency. Longer amplicons require more time and are more sensitive to template quality.

Primer design for RPA is notoriously difficult to predict computationally. The interaction between the recombinase, the primer, and the target DNA is influenced by local sequence context, including the presence of secondary structures in the target and the thermodynamic stability of the primer-target duplex. Most successful RPA assays are developed empirically, with multiple primer pairs screened to identify those that provide robust amplification. Commercial software and web-based tools, such as the TwistDx primer design tool, can generate candidate primer pairs, but experimental validation remains essential.

Isothermal Reaction Conditions

The standard RPA reaction is performed in a volume of 25–50 µL and contains the following components at approximate concentrations:

Recombinase (UvsX): 100–200 ng/µL
SSB (gp32): 400–800 ng/µL
Bsu DNA polymerase: 30–60 ng/µL
ATP: 2–3 mM
dNTPs: 200 µM each
Primers: 400–500 nM each
Creatine kinase / phosphocreatine: ATP regeneration system
Polyethylene glycol (PEG): 3–5% (w/v), typically PEG-35,000
Dithiothreitol (DTT): 2–5 mM
Tris-acetate buffer: 50 mM, pH 7.9–8.4
Magnesium acetate: 10–14 mM (added last to initiate the reaction)

The reaction is typically carried out at 37–42°C. The optimal temperature depends on the specific assay and the source of the enzymes; some formulations work better at 39°C, while others prefer 42°C. The reaction is initiated by adding magnesium acetate, which is required for recombinase and polymerase activity. Because magnesium is sequestered by the other components, it must be added in excess and is therefore the final component introduced.

The ATP regeneration system (creatine kinase and phosphocreatine) is essential for maintaining ATP levels throughout the reaction. Without it, ATP is rapidly depleted by the recombinase's ATPase activity, and the reaction stalls within minutes.

RPA Reaction Kinetics and Optimization

Temperature Dependence

RPA operates optimally between 37°C and 42°C, with the exact optimum depending on the specific enzyme formulation and primer sequences. At temperatures below 37°C, recombinase activity decreases, and the reaction slows considerably. At temperatures above 42°C, the recombinase and SSB proteins begin to denature, and the reaction efficiency drops sharply.

The low operating temperature of RPA is both a strength and a constraint. On one hand, it allows the reaction to be performed with minimal equipment—a simple heat block, a water bath, or even body heat can maintain the required temperature. On the other hand, the narrow temperature window means that precise temperature control is necessary for reproducible results. In field settings, this is typically achieved using commercially available battery-powered incubators or chemical heat packs.

Temperature also affects the specificity of primer binding. At lower temperatures, the recombinase-mediated strand invasion is more permissive, potentially allowing mismatched primers to invade and extend. At higher temperatures, specificity improves, but the overall reaction efficiency decreases. For most applications, 39°C represents a good compromise between speed and specificity.

Primer and Probe Design

Optimization of RPA reactions often begins with primer design. Because RPA primers are long (30–35 nucleotides), they have more opportunity for unintended interactions, including primer-dimers and off-target binding. Several strategies can improve the likelihood of successful amplification:

Screen multiple primer pairs: Design 3–5 primer pairs targeting different regions of the amplicon and test each in the RPA reaction. Typically, 1–2 of these will work well, while others will fail or produce non-specific products.

Use a "primer walk" approach: If the initial primer pairs fail, design additional primers shifted by 5–10 nucleotides along the target sequence. This approach often resolves issues related to local secondary structure or sequence context.

Avoid long homopolymer regions: Runs of 5 or more identical nucleotides, particularly G or C, can promote secondary structure and reduce recombinase loading efficiency.

Consider the amplicon length: For maximum sensitivity, keep the amplicon between 80 and 150 base pairs. Longer amplicons require more time for complete synthesis and are more sensitive to template degradation.

For real-time detection, RPA uses specific fluorescent probes that are distinct from PCR probes. The most common probe format is the exo probe, which contains a tetrahydrofuran (THF) abasic site flanked by a fluorophore and a quencher. The probe also carries a 3' block (typically a phosphate or C3 spacer) to prevent extension. When the probe hybridizes to its target sequence, the Bsu polymerase's 5'→3' exonuclease activity cleaves the THF site, separating the fluorophore from the quencher and generating a fluorescent signal. This mechanism is analogous to the 5' nuclease activity used in TaqMan PCR, but it operates at the constant reaction temperature.

Enhancing Sensitivity and Specificity

Several additives and modifications can improve RPA performance:

Betaine: At concentrations of 0.5–1 M, betaine reduces the melting temperature of DNA and can improve amplification efficiency, particularly for GC-rich targets.
DMSO: At 2–5% (v/v), dimethyl sulfoxide can help disrupt secondary structures in the template and improve primer accessibility.
Formamide: At low concentrations (1–3%), formamide can increase specificity by reducing non-specific primer binding.
Carrier RNA or DNA: Adding 50–100 ng/µL of carrier nucleic acid (e.g., yeast tRNA or salmon sperm DNA) can reduce non-specific adsorption of primers and enzymes to tube surfaces, improving reaction efficiency.

Sensitivity can also be enhanced by increasing the reaction time. While RPA products are often detectable within 5–10 minutes, allowing the reaction to proceed for 20–40 minutes can increase the yield of amplicons and improve the sensitivity of downstream detection methods.

Detection Methods for RPA Products

Agarose Gel Analysis

The simplest method for detecting RPA products is agarose gel electrophoresis. RPA amplicons (typically 100–200 base pairs) can be visualized on a 2–3% agarose gel stained with ethidium bromide, SYBR Safe, or GelRed. However, there are important caveats:

RPA products are not discrete bands: Because RPA generates concatemeric products and partially extended fragments, the amplicon often appears as a smear rather than a sharp band. This is normal and should not be interpreted as a failed reaction.

Post-amplification purification is required: The high protein content of the RPA reaction (recombinase, SSB, polymerase) can interfere with gel loading and electrophoresis. A simple purification step, such as phenol-chloroform extraction or a commercial PCR cleanup kit, is recommended before gel analysis.

Confirmation of product identity: To confirm that the amplified product corresponds to the intended target, the gel-purified product can be digested with a restriction enzyme that cuts within the amplicon, or it can be sequenced.

For educational and research purposes, gel electrophoresis remains a valuable tool for RPA product analysis, but it is not suitable for point-of-care applications where rapid, instrument-free detection is required.

Real-Time RPA with Exo Probes

Real-time RPA uses exo probes to generate a fluorescent signal that is monitored continuously during the reaction. The reaction is performed in a fluorometer or a real-time PCR instrument set to a constant temperature of 39°C. Fluorescence is measured every 30–60 seconds, and the time at which the signal rises above background (the "threshold time" or Tt) is inversely proportional to the initial template concentration.

Real-time RPA offers several advantages:

Quantification: By comparing Tt values to a standard curve generated from known template concentrations, the initial copy number can be estimated.
Speed: Positive reactions are typically detected within 5–15 minutes.
Closed-tube detection: Because the fluorescence is measured without opening the tube, the risk of amplicon contamination is reduced.

The exo probe is a 46–52 nucleotide oligonucleotide that contains a THF site positioned between the fluorophore and quencher. The probe sequence is designed to hybridize to one strand of the amplicon, with the THF site located within the probe. The 5' end of the probe carries a fluorophore (e.g., FAM, HEX, or Cy5), and the 3' end carries a quencher (e.g., BHQ-1 or BHQ-2). The 3' end is also blocked with a phosphate group to prevent extension by the polymerase.

During the reaction, the probe hybridizes to its complementary sequence on the amplicon. The Bsu polymerase, which possesses 5'→3' exonuclease activity, cleaves the probe at the THF site, separating the fluorophore from the quencher and producing a fluorescent signal. Because the probe is cleaved only when it is hybridized to the target, the signal is specific to the intended amplicon.

Lateral Flow Readout

Lateral flow (dipstick) detection is the most portable and user-friendly method for RPA product detection. This approach combines RPA with a nucleic acid lateral flow immunoassay, similar to the technology used in pregnancy tests.

For lateral flow detection, RPA primers are labeled with haptens—small molecules that can be recognized by antibodies. Typically, the forward primer is labeled with carboxyfluorescein (FAM) or digoxigenin (DIG), and the reverse primer is labeled with biotin. After amplification, the reaction mixture is applied to a lateral flow strip that contains:

A sample pad: Where the reaction mixture is applied.
A conjugate pad: Containing gold nanoparticle-labeled anti-FAM (or anti-DIG) antibodies.
A nitrocellulose membrane: With two test lines—a test line containing streptavidin (which binds biotin) and a control line containing species-specific anti-IgG antibodies.
An absorbent pad: That wicks the liquid through the strip.

As the reaction mixture migrates through the strip, the gold-labeled antibodies bind to the FAM-labeled amplicons. These complexes then bind to the streptavidin at the test line via the biotin on the reverse primer, producing a visible red line. The control line captures excess gold-labeled antibodies, confirming that the strip functioned correctly.

Lateral flow detection is rapid (2–5 minutes), requires no instrumentation, and provides a simple yes/no answer. It is widely used in point-of-care diagnostics and field testing applications.

Applications of RPA in Diagnostics and Field Testing

Infectious Disease Diagnostics

RPA has been applied to the detection of a wide range of pathogens, including bacteria, viruses, and parasites. Its low operating temperature, rapid reaction time, and tolerance to inhibitors make it particularly well-suited for point-of-care diagnostics in resource-limited settings.

Bacterial pathogens: RPA assays have been developed for the detection of Mycobacterium tuberculosis, Salmonella spp., Listeria monocytogenes, Neisseria meningitidis, and Chlamydia trachomatis. For tuberculosis, RPA targeting the IS6110 insertion element can detect as few as 10 copies of the M. tuberculosis genome in sputum samples, with results available in under 20 minutes.

Viral pathogens: RPA has been used to detect RNA viruses, including HIV, hepatitis C virus (HCV), dengue virus, Zika virus, and SARS-CoV-2. For RNA targets, a reverse transcription step is performed before or during RPA. In the one-step format, a reverse transcriptase enzyme (e.g., AMV or M-MLV reverse transcriptase) is added to the RPA reaction, and the combined RT-RPA reaction is performed at 39–42°C. This approach has been used to detect SARS-CoV-2 RNA in nasopharyngeal swabs with sensitivity comparable to RT-PCR.

Parasitic pathogens: RPA assays have been developed for malaria (Plasmodium spp.), sleeping sickness (Trypanosoma brucei), and leishmaniasis (Leishmania spp.). These assays are particularly valuable in endemic regions where laboratory infrastructure is limited.

Environmental and Agricultural Testing

RPA's tolerance to inhibitors makes it suitable for testing environmental and agricultural samples that contain substances that would inhibit PCR. For example:

Water quality testing: RPA can detect fecal indicator bacteria, such as Escherichia coli and Enterococcus spp., directly in water samples without DNA extraction.
Food safety: RPA assays have been developed for foodborne pathogens, including Salmonella, Campylobacter, and norovirus, in food matrices such as meat, dairy, and produce.
Plant pathogen detection: RPA can detect plant pathogens, including viruses, bacteria, and fungi, in leaf tissue, soil, and irrigation water.
Genetically modified organism (GMO) detection: RPA can amplify specific DNA sequences introduced into genetically modified crops, enabling rapid screening of food products.

The portability of RPA makes it ideal for on-site testing, where samples can be analyzed immediately without transport to a central laboratory.

Advantages and Limitations of RPA

Advantages Over PCR

RPA offers several distinct advantages over PCR, particularly for field and point-of-care applications:

Speed: RPA reactions reach detectable levels in 5–20 minutes, compared to 1–3 hours for PCR. This speed is critical in clinical settings where rapid diagnosis can guide treatment decisions.

Low temperature operation: The constant 37–42°C operating temperature eliminates the need for a thermocycler. A simple heat block, water bath, or even body heat can maintain the reaction temperature.

Portability: RPA reagents can be lyophilized (freeze-dried) and stored at room temperature for extended periods, enabling the distribution of complete reaction kits that require only the addition of water and sample.

Tolerance to inhibitors: RPA is remarkably tolerant to inhibitors present in crude samples, including blood, urine, saliva, and plant tissue. This reduces the need for extensive DNA purification, simplifying the workflow.

Compatibility with multiple detection formats: RPA products can be detected by gel electrophoresis, real-time fluorescence, or lateral flow strips, providing flexibility in detection methods.

Challenges and Drawbacks

Despite its advantages, RPA has several limitations that must be considered:

Primer design complexity: RPA primers must be 30–35 nucleotides long, and the rules for successful design are not fully understood. Many primer pairs fail to produce robust amplification, requiring extensive empirical screening.

Cost: RPA reagents, particularly the recombinant enzymes (UvsX, gp32, Bsu polymerase), are more expensive than PCR reagents on a per-reaction basis. This cost difference is significant for high-throughput applications.

Non-specific amplification: RPA can produce non-specific products, particularly when the template concentration is low or the reaction time is extended. This can complicate interpretation of results, especially with gel-based detection.

Limited multiplexing: While multiplex RPA (detecting multiple targets in a single reaction) has been demonstrated, it is technically challenging due to primer-primer interactions and the difficulty of designing multiple compatible primer pairs.

Amplicon size limitation: RPA is most efficient for amplicons under 200 base pairs. Larger amplicons amplify with reduced efficiency and may require longer reaction times.

Quantification is less precise: While real-time RPA can provide quantitative information, the dynamic range is narrower than that of real-time PCR, and the precision is generally lower.

Regulatory approval: RPA-based diagnostic tests have been slower to receive regulatory approval compared to PCR-based tests, limiting their clinical adoption.

Common Pitfalls and Troubleshooting in RPA

Primer Design Mistakes

The most common cause of RPA failure is poor primer design. Common mistakes include:

Problem: Primers shorter than 30 nucleotides fail to load sufficient recombinase and exhibit poor strand invasion. Solution: Redesign primers to be 30–35 nucleotides in length.

Problem: Primers with significant secondary structure (hairpins, self-dimers) sequester the primer and prevent recombinase loading. Solution: Use primer design software to check for secondary structure and avoid sequences with predicted stable hairpins.

Problem: Primers that form primer-dimers with each other consume primers and produce non-specific products. Solution: Check for primer-dimer formation using software tools and redesign primers if necessary.

Problem: Primers targeting GC-rich regions may fail due to stable secondary structure in the template. Solution: Choose a different target region or add betaine (0.5–1 M) to the reaction.

Contamination Control

Amplicon contamination is a significant risk in RPA, just as it is in PCR. Because RPA generates large amounts of product, even a tiny amount of carryover contamination can produce false-positive results. The following measures are essential:

Physical separation: Perform reaction setup in a dedicated area separate from where amplification products are handled.

Use of aerosol-resistant tips: Filter tips prevent aerosol contamination during pipetting.

Closed-tube detection: Use real-time fluorescence or lateral flow detection to avoid opening reaction tubes after amplification.

Decontamination: Treat surfaces and equipment with 10% bleach (sodium hypochlorite) followed by 70% ethanol to degrade contaminating DNA.

Include negative controls: Always include a no-template control (NTC) in every experiment to detect contamination.

Optimization Strategies

When an RPA reaction fails or produces weak amplification, systematic optimization is required:

Check the magnesium concentration: Magnesium is essential for recombinase and polymerase activity. If the reaction fails, try increasing the magnesium acetate concentration from 14 mM to 16–18 mM.

Verify the ATP regeneration system: The creatine kinase/phosphocreatine system is essential for maintaining ATP levels. Ensure that the creatine kinase is active and that the phosphocreatine concentration is adequate.

Test different temperatures: While 39°C is a good starting point, some assays work better at 37°C or 42°C. Test a temperature gradient to find the optimum.

Increase primer concentration: If amplification is weak, try increasing primer concentrations from 400 nM to 600–800 nM.

Extend the reaction time: Some assays require 30–40 minutes to reach detectable levels, particularly when the template concentration is low.

Purify the template: While RPA tolerates inhibitors, excessive inhibitors (e.g., high concentrations of heme in blood) can still inhibit the reaction. If the sample is heavily contaminated, perform a simple DNA purification step.

Test multiple primer pairs: If one primer pair fails, design and test additional pairs. This is often the most effective optimization strategy.

Practical Summary: Key Takeaways for Students

RPA is a powerful isothermal amplification technology that offers speed, portability, and simplicity compared to PCR. For exam preparation and laboratory work, the following points are essential:

Mechanism: RPA uses a recombinase (UvsX) to form a nucleoprotein filament with primers, which then invades double-stranded DNA and displaces one strand. SSB proteins (gp32) stabilize the displaced strand, and a strand-displacing polymerase (Bsu) extends the primer.

Temperature: RPA operates at a constant 37–42°C, eliminating the need for thermal cycling.

Primers: RPA primers are 30–35 nucleotides long, substantially longer than PCR primers.

Speed: RPA produces detectable amplicons in 5–20 minutes.

Detection: RPA products can be detected by gel electrophoresis, real-time fluorescence using exo probes, or lateral flow strips.

Applications: RPA is used for pathogen detection, point-of-care diagnostics, food safety testing, and environmental monitoring.

Limitations: RPA has complex primer design requirements, higher per-reaction cost, and limited multiplexing capability.

Frequently Asked Questions

What is RPA DNA amplification?

RPA (Recombinase Polymerase Amplification) is an isothermal nucleic acid amplification method that uses a recombinase enzyme to facilitate primer binding to double-stranded DNA, enabling exponential amplification at a constant temperature of 37–42°C. It was developed as an alternative to PCR for applications requiring rapid, portable, and minimally instrumented DNA detection.

How does RPA differ from PCR?

RPA differs from PCR in several fundamental ways: it operates at a constant low temperature (37–42°C) rather than through thermal cycling; it uses a recombinase-mediated strand invasion mechanism instead of thermal denaturation to separate DNA strands; it requires longer primers (30–35 nucleotides vs. 18–25 for PCR); and it produces detectable products in 5–20 minutes compared to 1–3 hours for PCR.

What are the key components of an RPA reaction?

The key components are: a recombinase (UvsX from bacteriophage T4), single-stranded DNA binding proteins (gp32), a strand-displacing DNA polymerase (Bsu from Bacillus subtilis), ATP and an ATP regeneration system (creatine kinase/phosphocreatine), dNTPs, forward and reverse primers (30–35 nucleotides), magnesium acetate, and a buffer system (typically Tris-acetate, pH 7.9–8.4, with PEG and DTT).

What is the optimal temperature for RPA?

The optimal temperature for RPA is 37–42°C, with 39°C being a common choice for many assays. The exact optimum depends on the specific enzyme formulation and primer sequences. Temperatures below 37°C reduce recombinase activity, while temperatures above 42°C denature the enzymes.

How are RPA products detected?

RPA products can be detected by: (1) agarose gel electrophoresis, where products appear as a smear rather than a discrete band; (2) real-time fluorescence using exo probes that are cleaved by the polymerase's 5'→3' exonuclease activity; or (3) lateral flow strips, where hapten-labeled primers (e.g., FAM and biotin) enable antibody-based detection on a dipstick.

What are common mistakes in RPA primer design?

Common mistakes include: designing primers shorter than 30 nucleotides, which fail to load sufficient recombinase; selecting primers with significant secondary structure or self-dimer potential; choosing primers that form primer-dimers; and targeting GC-rich regions with stable secondary structure. Successful RPA primer design typically requires screening multiple primer pairs empirically.

Can RPA be used for RNA detection?

Yes, RPA can detect RNA targets by adding a reverse transcription step. In the one-step format, a reverse transcriptase (e.g., AMV or M-MLV) is included in the RPA reaction, and the combined RT-RPA reaction is performed at 39–42°C. This approach has been used to detect RNA viruses, including SARS-CoV-2, HIV, and dengue virus.

Why is RPA considered a point-of-care technology?

RPA is considered a point-of-care technology because it combines rapid amplification (5–20 minutes) with low-temperature operation (37–42°C), eliminating the need for a thermocycler. RPA reagents can be lyophilized and stored at room temperature, and products can be detected using simple lateral flow strips that require no instrumentation. This makes RPA suitable for use in resource-limited settings, field testing, and bedside diagnostics.

Key Takeaways

RPA is an isothermal amplification method that operates at 37–42°C using recombinase-mediated strand invasion instead of thermal denaturation.
The three core enzymes are UvsX recombinase, gp32 single-stranded DNA binding protein, and Bsu DNA polymerase.
RPA primers are 30–35 nucleotides long, and amplicons are typically 100–200 base pairs.
RPA produces detectable products in 5–20 minutes, making it significantly faster than PCR.
Detection methods include gel electrophoresis, real-time fluorescence with exo probes, and lateral flow strips.
RPA is highly tolerant to inhibitors and works with crude samples, making it ideal for point-of-care diagnostics and field testing.
The main limitations are complex primer design, higher reagent cost, and limited multiplexing capability.